Biotech Week articles from December 2003

Biotech Week archives from December 2003

Team developing "Flu Chip" for fast, accurate diagnosis.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A team of researchers at the University of Colorado at Boulder is developing a "Flu Chip" that will aid physicians in swiftly diagnosing respiratory illness for future flu seasons. The Flu Chip...

Imaging damaged brain cells in living mice provides clues to dementia.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Using recently developed techniques for imaging individual cells in living animals, a team led by researchers at Washington University School of Medicine in St. Louis has watched as Alzheimer-like brain...

Genetic mutations resulting in delayed puberty are focus of study.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Identifying genetic mutations that delay puberty in a small number of children may also lead to better infertility treatment and birth control, says a Medical College of Georgia physician-scientist. ...

Nasal or rectal administration of glycyrrhizin offers good bioavailability.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Nasal or rectal administration of glycyrrhizin offers good bioavailability. According to recent research published in the International Journal of Pharmaceutics, "the purpose of this study was to...

Chromotest updates presented at American Society of Human Genetics meeting.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Ikonisys, Inc., a company focused on cell-based diagnostic products for the obstetrical and oncology markets, announced a major achievement in its development of Chromotest, a test to detect Down...

Alzhemed open-label phase II extension study demonstrates cognitive benefits.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Neurochem, Inc., (NRM) announced positive results on cognitive function as measured by ADAS-cog of patients suffering from mild-to-moderate Alzheimer Disease (AD) in an open-label phase II extension...

Care inconsistent for heart patients.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A third of heart failure patients left hospitals without some of the tried-and-true therapies that could add years to their lives, according to one of the largest studies of its kind, reported at the...

Pain medication maker reports royalty income increased 23%.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A.P. Pharma, Inc., (APPA) reported financial results for the 3 months ended September 30, 2003, reflecting increased royalty income and contract revenues. A.P. Pharma reported that total revenues...

Polymorphisms in DNA repair genes may be linked to immunosuppression, cancer.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Polymorphisms in DNA repair genes may be linked to immunosuppression, cancer. "When the sun damages the skin, it also impairs the DNA. The DNA repair system is needed to maintain the genetic...

Motion Media forges alliance with telemedicine company.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Motion Media Technology (MMD) announced a strategic distribution alliance with AMD Telemedicine, a provider of medical devices for the telemedicine market. As part of this alliance, Motion Media's...

Neugene maker reports net loss of $0.15 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) reported financial results for the 3 and 9 months ended September 30, 2003, and provided an update on its clinical pipeline. For the third quarter of 2003, the company...

Elevated cytokine levels in adipose tissue suppress adiponectin output in HALS patients.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Elevated cytokine levels in adipose tissue suppress adiponectin activity in HIV lipodystrophy patients. According to published research from Denmark, "Human immunodeficiency virus (HIV)-associated...

Negative effects of saquinavir hard gel treatment subside over time.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The negative effects of saquinavir hard gel treatment on the overall outcome of HIV therapy subside over time. "Saquinavir hard gel capsule (hgc), the first human immunodeficiency virus (HIV)...

Cell therapy company launches direct stock purchase program.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that registered shareholders of the company can purchase up to an aggregate of 10 million newly issued shares of its stock through Aastrom's Direct Stock...

Glucerna weight loss shakes for people with diabetes wins award.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories' (ABT) Ross Products Division announced that Glucerna Weight Loss Shakes were judged to be the overall Best Taste Award winner by the professional chefs of the American Culinary...

Generic drug maker reports 38.9% increase in sales.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Able Laboratories, Inc., (ABRX, AAB) announced financial results for the 3 months ended September 30, 2003. For the third quarter of 2003, the company reported net sales of $20.9 million, a 38.9%...

Molecular assay enables rapid, accurate detection of mutant mycobacterial katG.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A novel real-time polymerase chain reaction (PCR) assay can quickly and accurately identify TB strains carrying katG resistance mutations. "The emergence of drug-resistant strains of Mycobacterium...

First human trial of West Nile vaccine to begin.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Acambis (ACAM) announced the start of a phase I trial of its investigational vaccine against West Nile virus, ChimeriVax-West Nile. Since it was first identified in New York in 1999, the West Nile...

Assay maker reports loss of $0.14 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aclara BioSciences (ACLA) reported financial results for the 3 months ended September 30, 2003. Revenue for the 3 months ended September 30, 2003, was $276,000, compared to revenue for the 3 months...

The LeJour vertical mammoplasty pattern for skin-sparing mastectomy.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The LeJour vertical mammoplasty pattern for skin-sparing mastectomy. According to recent research published in the journal Annals of Plastic Surgery, "An application of the LeJour vertical mammoplasty...

Two patents granted for treatment of inflammatory diseases.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Adenosine Therapeutics, LLC, announced the issue of two United States patents for the treatment of a wide-ranging group of inflammatory diseases with adenosine A2A agonists. The patents are...

Pain management drug maker announces pricing of common stock.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Adolor Corporation (ADLR) announced the pricing of a public offering of 6,000,000 shares of its common stock at $17.25 per share. The gross proceeds from the offering are expected to be $103.5...

Ophthalmology company completes purchase of manufacturing facility.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Advanced Medical Optics, Inc., (AMO, AVO) announced that its Spanish subsidiary has completed the purchase of an existing manufacturing facility in Madrid, Spain, from Alcon CUSI, S.A., a subsidiary of...

Sheep are useful models for studying bone density.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Sheep are useful models for studying bone density. According to a study from New Zealand, "bone density (BD) is an important factor in osteoporotic fracture risk in humans. However, BD is a complex...

NHGRI funds large-scale genomic sequencing project.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corp., a provider of genomic services and nucleic acid purification products to the life sciences industry, announced that it has been awarded a grant from The National Human Genome...

First 60-mer microarray for rice commercialized.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A), in collaboration with Japan's National Institute of Agrobiological Sciences (NIAS), has commercialized the first 60-mer oligonucleotide microarray for the study of rice,...

Cre-mediated recombination efficiency determinable with immediate visual system.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Cre-mediated recombination efficiency can be determined using an immediate visual system prior to full examination of the phage library created. "Diversity in phage antibody libraries is important...

Reactive oxygen species exacerbate the effects of hepatitis B virus X protein.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Reactive oxygen species exacerbate the effects of hepatitis B virus X protein. According to published research from South Korea, "HBx (hepatitis B virus X) viral oncoprotein is a multifunctional...

Menstrual cycle influences baroreflex heart rate control.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Baroreflex regulation of cardiac activity is influenced by the menstrual cycle in women. Researchers in Japan conducted a study "to determine baroreflex control of heart rate (HR) to hypotensive and...

Hemodialysis company reports per share loss of $0.19.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aksys, Ltd., (AKSY) reported results for the quarter ended September 30, 2003. For the third quarter of 2003, Aksys reported total revenues of $411,000 compared to $169,000 for the third quarter of...

Device company's executives enter into Rule 10b5-1 trading programs.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alaris Medical Systems, Inc., (AMI) announced that several executives, including David L. Schlotterbeck, president and chief executive officer, have adopted pre-arranged trading plans permitted under...

Chemistry drug company reports 41.6% increase n revenue.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Albany Molecular Research, Inc., (AMRI) reported financial results for the quarter and 9-month period ending September 30, 2003. Total revenue for the third quarter of 2003 increased by $13.3...

Drug delivery company reports loss of $0.31 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) reported its financial results for the 3-month period ended September 30, 2003. The net loss on a GAAP basis for the quarter ended September 30, 2003, was $26.2 million or...

MRI useful for detecting asymptomatic spinal arachnoiditis in TBM patients.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Magnetic resonance imaging (MRI) is a valuable tool for detecting asymptomatic spinal arachnoiditis in tuberculous meningitis (TBM) patients. "Spinal arachnoiditis is one of the common and disabling...

Oncology company reports loss of $0.19 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) reported financial results for the third quarter of 2003. For the 3 months ended September 30, 2003, the company reported a net loss of $5.0 million, or $0.19 per...

510k market clearance granted for catheters with thermal regulation system.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Alsius Corp. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ICY and Fortius Catheters in combination with the CoolGard 3000 Thermal...

Pharmaceutical company boosts sales by 13% worldwide.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Altana AG (AAA; ALT) reported sales of around EUR 2 billion for the first 9 months of 2003, up 5% on the equivalent previous year's figure. "Despite the worldwide economic slump, the weak dollar,...

Phase I/II study initiated treating diabetes with encapsulated replacement islets.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AmCyte, Inc., announced the initiation of a phase I/II clinical safety trial treating diabetic patients with transplanted replacement islets without long-term immune suppression. Patient enrollment...

Data: SPARC Sling System is a safe and effective treatment for women.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Landmark 12-month data presented at the International Urogynecological Association meeting in Buenos Aires, Argentina, provides the strongest evidence to date that American Medical System's (AMMD)...

Caesarean delivery impacts younger infants with hyaline membrane disease.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Caesarean delivery impacts younger infants with hyaline membrane disease. "A hospital-based case-control study was conducted to examine the relationship between hyaline membrane disease (HMD) and...

Lilly purchases integrated cellular screening system.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amersham (AHM) announced that Eli Lilly and Co. (LLY) has purchased an integrated suite of cellular screening technology and licenses to help in the identification of potential therapeutics in its drug...

Custom lab system designed for breast cancer project.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amersham Biosciences, the life sciences business of Amersham (AHM), has signed an agreement with the Windber Research Institute to develop a customized Scierra Solutions Laboratory Workflow System to...

Medarex announces achievement of milestone in agreement.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Medarex, Inc., (MEDX) has achieved a significant milestone under its 1999 agreement with Amgen, Inc. The achievement of this milestone will trigger an undisclosed payment to Medarex. "We are...

Metabolic disease drug maker reports loss of $0.40 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) reported financial results for the third quarter ended September 30, 2003. The company reported a net loss of $37.5 million, or $0.40 per share, and $105.5...

FDA approval granted for loratadine.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that the U.S. Food and Drug Administration (FDA) has approved the marketing of its Abbreviated New Drug Application (ANDA) for its loratadine orally disintegrating...

Tissue, bone repair company posts 27% increase in revenue.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) announced financial results for the third quarter and 9-months ended September 30, 2003. For the third quarter, Anika posted revenue of $3,688,000, a 27% increase,...

Animas IR 1200 receives FDA approval.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Animas Corporation has received approval from the U.S. Food and Drug Administration (FDA) for the Animas IR 1200 insulin pump. This approval marks a major milestone for Animas, as well as the...

Data on AMD3100 to be presented at ASH.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced that a number of clinical and preclinical abstracts on AMD3100, a rapid and potent stem cell mobilizer, have been accepted for presentation at the American Society of...

Two new members added to board at drug delivery company.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that two new members have joined its Board of Directors effective October 31, 2003. Anton Gueth was elected to a 3-year term at the Annual Meeting of...

Eric von Hofe named VP of technology development.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology, Inc., (GNBT) announced that its Antigen Express subsidiary for developing novel immunomedicines has appointed Eric von Hofe, PhD, as vice president of technology development...

Immunotherapeutics company hires new VP.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced that Renu Gupta, MD, has joined the company as senior vice president of development, a new position that will be responsible for regulatory affairs, clinical...

Broad potential reported for R1549 highlighted by favorable tolerability profile.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Antisoma plc, announced final results from its pilot phase II study of R1549 in gastric cancer. The trial, which has been funded since November 2002 by Antisoma's co-development partner, Roche,...

Memorial Sloan-Kettering signs with telemedicine company.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Apollo Telemedicine, Inc., announced that Memorial Sloan-Kettering Cancer Center is installing its dynamic telediagnostic systems to create real-time visual connection between the pathologist in the...

Genome-wide human genetic variation map complete.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Applied Biosystems Group (ABI), an Applera Corporation business, announced that it has completed the development of a genome-wide human genetic variation map based on single nucleotide polymorphisms...

Alliance with the Cleveland Clinic uses imaging system in cancer research.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Applied Imaging Corp. announced the formation of a clinical research imaging collaboration with the Department of Anatomic Pathology at The Cleveland Clinic Foundation. As part of this...

Insulin system maker reports loss of $0.08 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM) announced financial results for the third quarter and 9 months ended September 30, 2003. Contract revenues for the quarter were $9.8 million, compared to $6.0 million for...

Biotech company reports loss of $0.21 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the first quarter of fiscal 2004, ended September 30, 2003. During the first quarter of fiscal 2004, Array reported total revenue of...

Low infection rate seen in Arrow Lionheart European trial.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- The results of the first study of the Arrow LionHeart, a heart assist device conceived of and developed at Penn State College of Medicine in cooperation with Arrow International, Inc., show low...

Clinical mass spectrometry in neuroscience proteomics reviewed.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Researchers have reviewed the application of clinical mass spectrometry to the areas of proteomics and peptidomics in neuroscience. According to a study from Sweden, "In this review we discuss the...

Warfarin efficacy matched by new thrombin inhibitor ximelegatran.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- by Richard Hyer, NewsRx correspondent - In the largest trial of atrial fibrillation ever conducted, the new oral direct thrombin inhibitor ximelegatran compared favorably with dose-adjusted warfarin in...

Inflammatory diseases drug maker files resale registration statement with SEC.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- AtheroGenics, Inc., (AGIX) announced that it has filed a resale registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) pertaining to its Convertible Notes issued on...

Richmond to resume duties as interim CFO at drug delivery firm.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced that Brian G. Richmond, the company's former chief financial officer, will serve as interim chief financial officer. In August, the company announced the...

Allogeneic RIST could be outpatient procedure.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Reduced intensity stem cell allotransplantation can be feasibly performed as an outpatient procedure. "Allogeneic stem cell transplantation (allo-SCT) after a reduced-intensity conditioning (RIC)...

High-dose methadone linked to QT prolongation and Torsades de Pointes in HIV patients.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- High-dose methadone therapy may cause QT prolongation and Torsades de Pointes in HIV patients. According to published research from Spain, "Four patients infected with human immunodeficiency virus...

AlphaNet to provide services to emphysema patients who rely on Zemaira.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Aventis Behring, LLC, announced an agreement with AlphaNet, Inc., a not-for-profit health management company, to provide health management and support services to patients who rely on Zemaira...

IND application filed with FDA For AV201.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) seeking clearance to enter clinical testing for AV201, its drug for the treatment...

Neurological disease biotech company reports loss of $0.07 per share.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Axonyx, Inc., (AXYX) announced its results for the third quarter ended September 30, 2003. The company reported a net loss to shareholders of $1,803,000 or $0.07 per share for the third quarter of...

Introcan Safety IV Catheter helps reduce needle sticks.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- B. Braun Medical, Inc., announced that it has signed a purchasing contract with Consorta, Inc., a leading group purchasing and resource management company, for the B. Braun Introcan Safety IV Catheter,...

Canadian study confirms women with implants require more medical care.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A new study by epidemiologists at the British Columbia Centre of Excellence for Women's Health, finds that Canadian women with breast implants use much more medical services than other women of the same...

Three disease compounds acquired from Sankyo.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- BTG (BGC) has acquired the intellectual property rights to a portfolio of preclinical compounds designed to treat Alzheimer disease, from Sankyo Co., Ltd., Japan. The portfolio encompasses three...

Seasonale maker reports 41% increase in revenue.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., (BRL) reported net earnings of $38.5 million, or $0.55 per fully diluted share for the first quarter of fiscal 2004 ended September 30, 2003, as compared to net earnings of...

Bristow named general counsel at dermatology company.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Barrier Therapeutics, Inc., an emerging biopharmaceutical company focused on the field of dermatology, announced that Albert C. Bristow has been appointed to the position of General Counsel. ...

FDA accepts NDA for ophthalmic anti-inflammatory/antibiotic.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Bausch & Lomb (BOL) and Pharmos Corporation (PHRM) announced that the U.S. Food and Drug Administration (FDA) has accepted for review Bausch & Lomb's New Drug Application for an...

Corporate VP of global quality management named at pharmaceutical firm.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Baxter International, Inc., (BAX) announced that its board of directors has elected Lawrence T. Gibbons to the corporate officer position of corporate vice president - global quality management. ...

Supplement filed for approval of needless device used with Kogenate FS.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Bayer Biological Products (BP) announced the filing of a pre-approval supplement for Bio-Set, a new needleless device for the reconstitution and use of Kogenate FS (Antihemophilic Factor [Recombinant],...

Albumin reduces mortality in coronary artery bypass graft surgery.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- According to a recently published study, albumin, used as a blood volume expander in coronary artery bypass graft (CABG) surgery, is associated with a significantly lower incidence of mortality compared...

New IGIV, Gamunex, now available.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Bayer HealthCare, LLC, biological products division's (Bayer BP) new and advanced immunoglobulin intravenous (IGIV), Gamunex, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified,...

IL-12B UTR mutation does not affect TB risk.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- A mutation in a gene coding for the cytokine interleukin (IL)-12 does not influence susceptibility to tuberculosis infection. According to published research from Texas, IL-12 "plays a pivotal role...

Family factors affect drug use by Mexican American teens.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- As Mexican American teens become more "Americanized," their alcohol, tobacco and drug use increases to match that of white teens, many studies have shown. New research suggests that this acculturation...

Heat shock protein-mediated antigen targeting increases DNA vaccine potency.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Secretory heat shock protein-mediated antigen targeting increases DNA vaccine potency. "In an effort to enhance the potency of DNA vaccines, we have developed a new strategy to increase antigen...

Medical device firm reports 9% increase in revenue.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Becton, Dickinson and Company (BD) (BDX) reported record quarterly revenues of $1.177 billion for the fiscal fourth quarter ended September 30, 2003, an increase of 9% from the same period a year ago....

Pharmaceutical companies are capitalizing on biomarker potential.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Leading-edge pharmaceutical and diagnostic companies are increasingly harnessing the potential of biomarker research to gauge the potential of compounds before they reach costly clinical trial...

Sex differences exist in effect of obesity on serum gonadotropin levels.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Sex differences exist in the effect of obesity on 24-hour mean serum gonadotropin levels. "To determine the effect of obesity on serum gonadotropin levels and any possible sex difference in the...

Third quarter service revenue rises 25% at imaging company.
December 3, 2003... 2003 DEC 3 - (NewsRx.com & NewsRx.net) -- Bio-Imaging Technologies, Inc., (BIT) announced its financial results for the third quarter and 9 months ended September 30, 2003. Total revenue for the third quarter of 2003 reached $6.3 million,...